Increased Expression of CD8 Marker on T-cells in COVID-19 Patients
Overview
Affiliations
Background: Cell-mediated immunity including T-cells (T helper and cytotoxic) plays an essential role in efficient antiviral responses against coronavirus disease-2019 (COVID-19). Therefore, in this study, we evaluated the ratio and expression of CD4 and CD8 markers in COVID-19 patients to clarify the immune characterizations of CD4 and CD8 T-cells in COVID-19 patients.
Methods: Peripheral blood samples of 25 COVID-19 patients and 25 normal individuals with similar age and sex as the control group were collected. White blood cells, platelets, and lymphocytes were counted and CD4 and CD8 T lymphocytes were evaluated by flow cytometry.
Results: The number of white blood cells, lymphocytes, and platelets were reduced significantly in COVID-19 patients (P < 0.05). The difference in CD4:CD8 ratio, CD4 T-cell frequency, CD8 T-cell frequency, and CD4 mean fluorescence intensity (MFI) was not significant between COVID-19 patients and healthy individuals (P > 0.05); however, the CD8 MFI increased significantly in COVID-19 infected patients (P < 0.05).
Conclusion: Although, there is no significant difference in the ratio of CD4 to CD8 between two groups, the expression level of CD8 in COVID-19 patients was significantly higher than the normal individuals. This result suggested that the cellular immune responses triggered by COVID-19 infection were developed through overexpression of CD8 and hyperactivation of cytotoxic T lymphocytes.
Di J, Ma X, Wu T, Qiao E, Salouti M, Zhong Y J Transl Autoimmun. 2024; 9:100255.
PMID: 39524116 PMC: 11550720. DOI: 10.1016/j.jtauto.2024.100255.
Pathophysiological, immunological, and inflammatory features of long COVID.
Bohmwald K, Diethelm-Varela B, Rodriguez-Guilarte L, Rivera T, Riedel C, Gonzalez P Front Immunol. 2024; 15:1341600.
PMID: 38482000 PMC: 10932978. DOI: 10.3389/fimmu.2024.1341600.
Effects of metformin therapy on HMGB1 levels in rheumatoid arthritis patients.
Zhang L, Zhou Y, Jiang S, Fan Y, Huang J, Xiao B Eur J Med Res. 2023; 28(1):512.
PMID: 37964313 PMC: 10648365. DOI: 10.1186/s40001-023-01476-x.
Ramon-Luing L, Flores-Gonzalez J, Angel Garcia-Rojas L, Islas-Munoz B, Volkow-Fernandez P, Chavez-Galan L Clin Exp Immunol. 2023; 215(2):190-201.
PMID: 37904542 PMC: 10847826. DOI: 10.1093/cei/uxad115.
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.
Shama , Mahmood A, Mehmood S, Zhang W Curr Issues Mol Biol. 2023; 45(9):7161-7182.
PMID: 37754237 PMC: 10528388. DOI: 10.3390/cimb45090453.